BREWIN DOLPHIN LTD - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
BREWIN DOLPHIN LTD ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$18,617
-32.8%
3,7160.0%0.00%0.0%
Q2 2021$27,721
+49.0%
3,716
+17.2%
0.00%0.0%
Q1 2021$18,608
+101.0%
3,170
+60.9%
0.00%0.0%
Q4 2020$9,2591,9700.00%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 50,714$94,8350.06%
Baker Brothers Advisors 3,140,473$5,872,6850.03%
VANCE WEALTH, INC. 39,266$73,4270.03%
CSS LLC/IL 258,814$483,9820.03%
SHELL ASSET MANAGEMENT CO 317,240$5930.02%
Steward Partners Investment Advisory, LLC 650,000$1,215,5000.02%
Alpine Global Management, LLC 30,000$56,1000.01%
HoyleCohen, LLC 74,408$139,1430.01%
BENDER ROBERT & ASSOCIATES 24,059$44,9900.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 86,212$161,2160.01%
View complete list of SUMMIT THERAPEUTICS INC shareholders